Tekla Capital Management LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 170 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,018,000
+6.0%
65,7430.0%0.04%0.0%
Q3 2020$960,00065,743
+328615.0%
0.04%
Q4 2017$0
-100.0%
20
-100.0%
0.00%
-100.0%
Q3 2017$8,308,000
+21.3%
756,6790.0%0.30%
+16.9%
Q2 2017$6,848,000
-11.9%
756,679
+25.0%
0.25%
-15.6%
Q1 2017$7,771,000
+65.2%
605,224
+21.0%
0.30%
+50.5%
Q4 2016$4,703,000
-3.4%
500,3240.0%0.20%
+7.0%
Q3 2016$4,868,000
+45.0%
500,3240.0%0.19%
+36.5%
Q2 2016$3,357,000
-24.8%
500,3240.0%0.14%
-27.9%
Q1 2016$4,463,000
-32.7%
500,3240.0%0.19%
-20.8%
Q4 2015$6,629,000
-49.1%
500,324
-59.5%
0.24%
-48.7%
Q3 2015$13,013,000
+0.3%
1,235,766
+159.1%
0.47%
-0.4%
Q2 2015$12,978,000
-11.1%
476,9660.0%0.47%
-18.8%
Q1 2015$14,600,000
+183.1%
476,966
+246.2%
0.58%
+140.2%
Q4 2014$5,157,000
+44.7%
137,766
+35.1%
0.24%
+44.3%
Q3 2014$3,563,000101,9660.17%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders